Bayview Pharmacy is pleased to present a specially compounded topical solution containing Minoxidil 6%, Estriol 0.1%, and Zinc Acetate 0.1%. This unique formulation is designed to address a range of dermatological conditions, including androgenic alopecia, female pattern hair loss, and hirsutism.

Minoxidil, a potent vasodilator, works by enhancing blood flow to the scalp, thereby stimulating hair growth. Estriol, a mild estrogen, aids in reducing the production of androgens, which can contribute to hair loss. Zinc Acetate, an essential mineral, plays a crucial role in reducing inflammation and promoting healthy hair growth.

This compounded topical solution offers a targeted approach to treating androgenic alopecia, female pattern hair loss, and hirsutism. It is designed to minimize hair loss, stimulate hair growth, and reduce inflammation. For optimal results, patients are advised to apply the solution to the affected area twice daily.

At Bayview Pharmacy, we are committed to providing high-quality, personalized healthcare solutions. If you have any questions or need further information about this compounded topical solution, please do not hesitate to contact us. Our team is always ready to assist you in finding the most suitable treatment for your condition.

Minoxidil 6%/Estriol 0.1%/Zinc Acetate 0.1% Topical Solution is a liquid formulation designed for external application to the skin. This solution is a versatile treatment option for various dermatological conditions, including androgenic alopecia, postmenopausal vulvovaginal atrophy, and acne vulgaris.

Minoxidil, a key ingredient in this formulation, is a vasodilator that enlarges hair follicles and promotes hair growth, making it an effective treatment for androgenic alopecia. Estriol, a weak estrogen, alleviates symptoms of postmenopausal vulvovaginal atrophy such as dryness, itching, and burning. Zinc Acetate, an anti-inflammatory agent, helps to reduce inflammation associated with acne vulgaris.

When using this topical solution, it is crucial to adhere to the directions provided by your healthcare provider. The solution should be applied to the affected area twice daily, and patients should not exceed the recommended dosage. Avoid contact with the eyes, nose, and mouth when applying the solution.

Patients should be aware that this solution may cause skin irritation, redness, or itching. If these side effects occur, discontinue use and contact your healthcare provider. Additionally, the solution may stimulate hair growth in areas other than the scalp.

It's important to note that Minoxidil 6%/Estriol 0.1%/Zinc Acetate 0.1% Topical Solution may interact with other medications, including oral contraceptives, anticoagulants, and antihypertensives. Therefore, patients should inform their healthcare provider of all medications they are currently taking before starting this treatment.

If you have any questions or concerns about Minoxidil 6%/Estriol 0.1%/Zinc Acetate 0.1% Topical Solution, please do not hesitate to reach out to us at Bayview Pharmacy.

Minoxidil 6%/Estriol 0.1%/Zinc Acetate 0.1% Topical Solution is a specially compounded formulation designed to address a range of dermatological conditions. This topical solution is a liquid formulation intended for external application to the skin, offering a targeted treatment approach for various skin conditions.

The active ingredients in this formulation include Minoxidil, Estriol, and Zinc Acetate. Minoxidil, a potent vasodilator, enhances blood flow to the scalp, stimulating hair growth. Estriol, a form of estrogen, works to alleviate inflammation and itching. Zinc Acetate contributes to the reduction of redness and irritation. Together, these ingredients offer a comprehensive treatment for skin conditions such as psoriasis, eczema, and seborrheic dermatitis.

When applied topically, Minoxidil 6%/Estriol 0.1%/Zinc Acetate 0.1% Topical Solution works to mitigate inflammation, itching, and redness associated with these skin conditions. It also promotes hair growth in areas affected by hair loss. For optimal results, the solution should be applied twice daily to the affected area and used consistently for at least two months.

It is crucial to note that Minoxidil 6%/Estriol 0.1%/Zinc Acetate 0.1% Topical Solution should not be used by pregnant or breastfeeding women due to potential risks to the fetus or infant. It is also advisable to consult with your healthcare provider before starting this medication, as it may interact with other medications or supplements you are currently taking.

If you have any questions about Minoxidil 6%/Estriol 0.1%/Zinc Acetate 0.1% Topical Solution or how it can help treat your skin condition, please do not hesitate to reach out. It is always important to find the best treatment option tailored to your specific needs.

This compounded formulation of Minoxidil 6%/Estriol 0.1%/Zinc Acetate 0.1% Topical Solution is a liquid formulation designed for external application to the skin. It is a versatile treatment option that delivers targeted medication and therapeutic agents to address a variety of dermatological conditions. It has been effectively used in the treatment of Androgenic Alopecia, Hirsutism, Female Pattern Baldness, Alopecia Areata, and Telogen Effluvium. Beyond hair loss conditions, it has also shown efficacy in treating skin conditions such as seborrheic dermatitis, psoriasis, and eczema, reducing inflammation and itching associated with these conditions.

Moreover, this formulation has been used to improve skin aesthetics, reducing the appearance of wrinkles and fine lines, improving skin tone and texture, and diminishing the visibility of scars and stretch marks. However, patients should be aware that this formulation may cause skin irritation, redness, and dryness. If any of these side effects occur, it is recommended to discontinue use and contact a healthcare provider. It is also important to note that this formulation should not be used on broken or irritated skin. For any questions or concerns regarding the use of this formulation, it is advised to consult with a healthcare provider.